Komen Greater Amarillo Homepage

SAVE THE DATE

2013 Race for the Cure

Saturday, September 28, 2013

Online Race registration opens late May

Passionately Pink for the Cure®
Are you inspired to save a life? Go Passionately Pink for the Cure® and turn your passion into action! Passionately Pink for the Cure is a fun and easy fundraising program that raises breast cancer awareness, inspires advocacy and honors those affected by the disease, all while impacting your local community. The premise is simple: Go pink to fight breast cancer! .
More

2013-2014 Grant Funds Available
Grant funds availabe.
More

2013 Race for the Cure Sponsorships Available
Local sponsorship is critical to our being able to support local breast cancer programs and national research grants. .
More

Komen Amarillo hires Mission Coordinator

The Greater Amarillo Affiliate would like to announce that JESSICA TUDYK has joined their organization as the new Mission Coordinator (Grants and Education). Jessica was born and raised in Canyon. She graduated from Baylor University with her Bachelor’s and Master’s in Community Health and Health Education. She is a Certified Health Education Specialist (CHES). Jessica will be responsible for oversight of the affiliate’s education programs, community outreach, advocacy, and grant administration.

Congratulations 2013 - 2014 Grant Recipients

Determined to save lives and end breast cancer forever, the Greater Amarillo Affiliate of Susan G. Komen ® has awarded 3 grants totaling $223,000 for programs providing breast cancer services in the Panhandle area. This year's recipients are The Don & Sybil Harrington Cancer Foundation, Moore County Hospital District and The Amarillo Area Breast Health Coalition.

Is ductal carcinoma in situ (DCIS) breast cancer?
Ductal carcinoma in situ (DCIS) is breast cancer, but it is non-invasive. About 55,000 new cases of DCIS are expected to be diagnosed among women in the U.S. in 2013. Learn more now.

How Komen's research investment has changed the breast cancer landscape
As we've come to understand more about the biology of breast cancer, Komen's research agenda has changed tremendously over the past 10-15 years. Read more about Komen's research investment.